Release Date: 20/02/18 12:34 Summary: ASX Market Release - Reinstatement Price Sensitive: Yes Download Document 82.57KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%